As Dubai prepares to welcome the new year with grand celebrations, Dubai Health has prepared its comprehensive readiness plan to ensure the health and safety of residents and visitors. The plan reflects Dubai Health’s commitment to providing high-quality patient care, leveraging the hospitals, clinics, and emergency resources across the health system.

Khalifa Baqer, Chief Operating Officer at Dubai Health, said, “At Dubai Health, we have developed a plan to ensure the provision of high-quality and comprehensive care during the New Year’s Eve celebrations, whether on-site or in our hospitals and clinics. This initiative reflects the dedication and exceptional efforts of our teams, whose commitment ensures the health and safety of all. We are also grateful for the close collaboration with the Dubai Events Security Committee and our partners, which has been instrumental in ensuring readiness.”

Comprehensive Readiness Plan

As part of the plan, Dubai Health will deploy 1,800 medical and administrative personnel across six hospitals and four clinics, ensuring uninterrupted access to high-quality healthcare services throughout the festivities. Facilities, including Rashid Hospital, Dubai Hospital, Al Jalila Children’s, Latifa Hospital, Jebel Ali Hospital, and Hatta Hospital, along with clinics in Nad Al Hamar, Al Barsha, Dubai International Airport, and Al Maktoum International Airport, will operate at full capacity. A fully equipped field hospital will be established near the Burj Khalifa, featuring eight treatment rooms and specialized teams in emergency medicine, internal medicine, surgery, and pediatrics. In addition, seven strategically located medical points, staffed by emergency specialists, will offer immediate care.

Dr. Sara Kazim, Chair of Emergency Medicine at Dubai Health, explained, “All emergency departments in Dubai Health hospitals are prepared to manage urgent cases, ensuring patients receive the best possible care. Our plan includes equipping emergency departments with the necessary medical equipment and supplies, increasing on-call doctors by 20%, enhancing rapid response coordination with Dubai Ambulance, and allocating additional treatment rooms. We thank our teams for their unwavering dedication and readiness to support the community during this large-scale event.”

Ensuring inclusivity for Dubai’s diverse population, multilingual teams will provide services in 13 languages, including Arabic, English, French, Chinese, Persian, Russian, Spanish, Hindi, Portuguese, Italian, Korean, German, Swahili, and sign language. Additionally, 20 patient transport vehicles will be on standby to facilitate smooth transfers for recovered patients, whether to their homes or back to event venues. For added convenience, Dubai Health is extending its homecare and telemedicine services, accessible via the call center on 80060. These services aim to ensure that residents and visitors can receive expert medical attention from their homes.

Dubai Health remains committed to ensuring all community members enjoy safe and memorable New Year’s Eve celebrations.

Key Figures:

• 1,800 medical and administrative staff deployed during the celebrations
• 6 hospitals and 4 clinics are operational 24/7
• 7 medical points staffed with emergency specialists
• 1 field hospital with 8 treatment rooms and specialized teams
• 20 vehicles available for patient transfers
• Homecare and telemedicine services can be accessed via 80060.

Dubai Chambers announced that it has signed a Memorandum of Understanding (MoU) with Al Jalila Foundation, donating AED15 million to support the Hamdan Bin Rashid Cancer Hospital, the first fully integrated and comprehensive cancer hospital in Dubai.

Dubai Chambers’ donation to the Hamdan Bin Rashid Cancer Hospital exemplifies their unwavering commitment to enhancing community welfare and supporting critical initiatives that improve quality of life.

The MoU was signed by His Excellency Abdul Aziz Abdulla Al Ghurair, Chairman of Dubai Chambers, and Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, at the Dubai Chambers’ headquarters.

His Excellency Abdul Aziz Abdulla Al Ghurair said: “In line with the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to strengthen social responsibility, Dubai Chambers is keen to support national projects that contribute to improving the quality of life and enhancing community services, thereby fostering social and economic development.”

Al Ghurair added: “Our cooperation with Al Jalila Foundation to support the Hamdan Bin Rashid Cancer Hospital reflects our commitment to the principles of social responsibility and the importance of charitable and humanitarian work, as part of our ongoing efforts to effectively contribute to serving the community.”

Expressing her gratitude for the donation, Her Excellency Dr. Raja Al Gurg said: “We are grateful to Dubai Chambers for their generous contribution toward establishing Dubai’s first comprehensive cancer hospital. Through this collaboration and the power of giving, Al Jalila Foundation is paving the way for enhanced care for cancer patients and their families in Dubai. This partnership aligns perfectly with our mission to foster a healthy and sustainable society, enhancing health and wellbeing through humanitarian, developmental, and community-focused efforts.”

Al Jalila Foundation is currently developing the Hamdan Bin Rashid Cancer Hospital, spanning 56,000 square meters. The hospital will feature 50 clinics, 30 clinical research areas, 60 infusion rooms, 10 urgent care rooms, five radiotherapy rooms, and 116 beds, complemented by 19 gardens spread across the campus. These gardens will offer patients space for recovery and opportunities to spend time outdoors with their families, promoting enhanced mental well-being.

The new facility will house a multidisciplinary team, including specialized nursing staff, and will provide integrated healthcare services from initial diagnosis through treatment, ensuring comprehensive care under one roof. Selected treatments and services will also be accessible to patients in their homes, ensuring continuity of affordable care and reflecting Dubai Health’s commitment to prioritizing patient needs.

The Dubai Academic Health Corporation (DAHC), AXDEV Global, and Pfizer Global announced a public-private partnership to enhance care for patients diagnosed with chronic illnesses, supported by an independent grant from Pfizer Global Medical Grants.

The goal of the collaboration is to establish an evidence-based model in performance and quality improvement to support the adoption of best practices and boost capacity development for patient care with chronic illnesses at the individual, team, practice, and health systems levels.

Dubai will serve as a test-bed to plan and implement the model, identified as the ideal city for the research given its diverse cultural population and unwavering support of its academic health system from the Dubai Academic Health Corporation.

The findings will then be scaled to enhance chronic illness care in low- and middle-income countries (LMICs) in Asia-Pacific, the Middle East, and North Africa.

The Dubai Academic Health Corporation will host the initiative at its medical university, Mohammed bin Rashid University of Medicine and Health Sciences (MBRU), and AXDEV will provide expert implementation research and project management across every step of the program.

All activities are supported by Pfizer’s independent grant including the research, development, and execution of medical education activities, toolkits and implementation science across multiple health centers in Dubai.

Through a research project out of MBRU, the research will take diabetes as a case example to apply and measure the impact of the interventions in four local health centers in Dubai. Today, diabetes is a chronic illness that affects almost one in every five adults in the UAE and is one of the leading causes of kidney failure globally.

The evidence and results gathered in Dubai will then be scaled to LMICs to reorganize chronic illness care and provide critical tools and education for clinicians, allied health professionals, staff and healthcare administrators.

Commenting on the importance of public-private partnerships, Dr. Hanan Alsuwaidi, Chief Business Officer of the Dubai Academic Health Corporation, said, “The healthcare industry has experienced significant changes since the pandemic. World-class healthcare systems are now turning to proficient partnerships to reimagine business models and access new capabilities. Public-private partnerships, like this one between the Dubai Academic Health Corporation, AXDEV and Pfizer, leverage the strength of all its members to accelerate the adoption of best practices in patient care.”

Suzanne Murray, Founder and CEO of AXDEV Group, stated, “This public-private collaboration, that will bring cutting edge education solutions for healthcare professionals and their teams to directly impact clinical practice, is a testimony that three major organizations, as well as the health centers involved, are committed to improving patient health outcomes with evidencebased and quality education and implementation research.”

Yasser El Dershaby, Vice President, MERA Regional Cluster Medical Lead, Pfizer, also commented on the importance of health equity. “Accessible healthcare for patients living with chronic illnesses is critical given that they are tethered to the healthcare system. Especially in LMICs, it has always been Pfizer’s goal to enhance health equity in underserved communities. Our new public-private partnership with The Dubai Academic Health Corporation and AXDEV Global brings us one step closer to bridging these gaps, and I look forward to the results from our initial research in Dubai.”

Dubai Health, the first integrated academic health system in Dubai, has signed a strategic partnership agreement with the Erada Centre for Treatment and Rehab. The agreement aims to enhance collaboration between both organizations, focusing on an integrated information system, as well as medical, academic and research initiatives. The partnership specifically aims to develop an advanced model of care for patients with substance abuse disorders.

The agreement creates the framework for cooperation in a wide range of areas including patient transfer for additional medical requirements, logistical support, information exchange, training, and development. In addition, Erada will collaborate with the Mohammed Bin Rashid University of Medicine and Health Sciences to develop educational programs related to substance abuse treatment, residency, and research.

His Excellency Dr. Amer Sharif, CEO of Dubai Health, stated: “The strategic partnership with the Erada Centre for Treatment and Rehab in Dubai is part of Dubai Health’s constant efforts to further develop the healthcare system in Dubai. It reflects our commitment to enhancing medical care and rehabilitation services, guided by our four missions: Care, Learning, Discovery and Giving. Through these missions, we aim to deliver world-class healthcare services and implement international best practices, positioning Dubai as a leading global model for advancing health for humanity.”

“Apart from offering effective treatment and rehabilitation services, the Erada Centre for Treatment and Rehab in Dubai actively contributes to framing policies, strategies, and plans. It also plays a vital role in raising awareness about preventive measures, significantly contributing to the overall development of Dubai’s healthcare system. Through this strategic partnership, we aim to leverage the centre’s expertise and high-quality services to enhance the capabilities of our healthcare system, in line with our Patient First promise.”

His Excellency Abdulrazaq Amiri, CEO of the Erada Centre for Treatment and Rehab in Dubai, emphasized the Centre’s commitment to reinforcing cooperation with Dubai’s government departments to promote exchange of experiences and enhance the quality of services for both citizens and residents, particularly in the field of addiction treatment and rehabilitation. Amiri praised Dubai Health for its role as a leading health institution in the emirate, noting that its goals and vision are in line with those of the Erada Centre.

Amiri commended Dubai Health for its support in meeting the Centre’s needs for medical services that complement its addiction treatments. These include dental care, emergency case management referred by the Centre, as well as medical, pharmaceutical and laboratory services.

Furthermore, Dubai Health supports the Erada Centre’s initiatives to establish a comprehensive framework to enhance the effectiveness of treating patients with substance abuse disorder in Dubai and the rest of the country.

The partnership marks a significant milestone in strengthening the collaboration between Dubai Health and the Erada Centre for Treatment and Rehab, reflecting their shared commitment to advancing healthcare services and rehabilitation in Dubai.

DP World Foundation has donated Dh15 million to Al Jalila Foundation to support the development of the Hamdan bin Rashid Cancer Hospital, highlighting its commitment to corporate social responsibility and community welfare.
The contribution is part of DP World Foundation's broader efforts to support vital healthcare services and improve access to quality healthcare for cancer patients.
The allocated funds will support the development of Dubai's first integrated cancer hospital, scheduled to open in 2026. The advanced healthcare facility, which is being established in collaboration with the Al Jalila Foundation, will feature 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus.
His Excellency Nasser Abdulla Al Neyadi, Chief Officer Group Security, Government Relations & Public Affairs (GRPA), and DP World Foundation, presented the contribution during a visit to the Al Jalila Foundation, including the Mohammed Bin Rashid Biomedical Research Centre, where he met with key healthcare officials and stakeholders.
HE Al Neyadi said: "We are deeply committed to making a real difference in society, and this donation reflects our dedication to supporting healthcare institutions and ensuring that quality care is accessible to everyone. We are proud to contribute to such a respected institution leading the way in cancer care and research. Together, we aspire to foster a healthier future for all."
Dr. Amer Al Zarooni, CEO of the Al Jalila Foundation, said: "We extend heartfelt gratitude to the DP World Foundation for their generous donation towards the Hamdan Bin Rashid Cancer Hospital. The collaboration exemplifies the transformative impact of partnerships in accelerating the delivery of critical healthcare services and further emphasizes Dubai Health's commitment to improving the health and well-being of our community.
Together, with the support of our partners, we are steadfast in our dedication to transforming lives and ensuring better health for everyone."
The philanthropic arm of DP World, DP World Foundation, is committed to promoting social responsibility and supporting those in need, regardless of nationality, race, or religion. Earlier this year, DP World Foundation contributed Dh 10 million to the Mothers' Endowment Campaign launched to support the education of millions around the world.

The Academic Guidance for Physicians Program helped applicants meet the requirements to enroll in medical residency programs in Canada and the US.

Dubai Health, the first integrated academic health system in Dubai has announced that 100% of its Emirati scholars from the Graduate Medical Education at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) have successfully secured training opportunities for medical residency programs in Canada and the US. This notable achievement was facilitated by the Academic Mentorship Program for Physicians, a flagship initiative under the Deanship of Graduate Medical Education at MBRU designed to support trainees in pursuing medical residency training programs in North America.

Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, said: “This is a very special moment for Dubai Health, celebrating the success of our young scholars who are pushing the envelope and getting outside of their comfort zones to pursue their graduate medical education abroad, which is a testament to the caliber of medical education, mentorship, and clinical training that is distinctively offered at MBRU, the University within Dubai's first integrated academic health system. This success not only reflects the individual achievements of our young doctors but also underscores Dubai Health's commitment to empowering local medical talent, ensuring that they receive opportunities to excel on the global stage. I'm very proud of these young doctors and very proud of the graduate medical education team that is supporting them.”

Professor Sulaiman AlEmran, Dean of Graduate Medical Education at MBRU, said: “We are honored by the accomplishments of our Emirati scholars and MBRU’s new Academic Mentorship Program for Physicians. These achievements reflect MBRU’s commitment to supporting trainees in their learning journey, aligning with Dubai Health’s goal to cultivate local medical talent in various medical fields,”

“The Deanship of Graduate Medical Education at MBRU implemented a standardized program for academic mentorship, offering comprehensive support to medical trainees aspiring to enroll in medical residency programs in Canada and the US. The initiative included meticulous review and optimization of trainees' academic performances and resumes, coupled with informative workshops addressing application requirements and refining personal interview skills. The program facilitated communication between trainees and prominent Canadian and American institutions, introducing them to Dubai Health, and provided diligent follow-up throughout all application stages and requirements,” he added.

A total of 11 trainees who participated in the academic mentorship program, successfully meeting all admission requirements and criteria for prestigious Canadian and American institutions, including the successful completion of medical licensing exams. The Deanship of Graduate Medical Education oversaw the review process of all documents, submitting them to numerous universities in Canada and the US in collaboration with UAE attachés.

Each applicant excelled in meeting the admission requirements, including personal interviews. Successful candidates have been accepted into several medical residency programs, such as internal medicine, emergency medicine, neurology, ophthalmology, orthopedic surgery, and diagnostic radiology. Notable institutions welcoming MBRU trainees include the University of Texas in the US, as well as Canadian universities such as McGill University, the University of British Columbia, the University of Alberta, the University of Toronto, McMaster University, and Queen's University.

This unprecedented accomplishment of securing 11 training opportunities across Canadian and American institutions is a pinnacle achievement in the UAE's healthcare landscape. Moreover, this success aligns seamlessly with Dubai Health's commitment to investing in developing national healthcare talents, fostering excellence in healthcare services, and championing learning and discovery to impact lives.

Dubai Health showcased its latest advancements in healthcare technology and innovation at GITEX, the biggest tech and startup show in the world. This year’s event theme centers on the integration of artificial intelligence (AI) across various sectors, with a particular focus on AI in health.

Teaming up with the Dubai Digital pavilion, Dubai Health is offering visitors a 20-minute journey that showcases how the integrated academic health system’s latest technological solutions are enhancing patient care and operational efficiency.

One of the key highlights of Dubai Health’s exhibit is the use of virtual reality (VR) technology at its Thalassemia Center, a solution currently being studied by Dubai Health’s Innovation and Digital Health team. This study aims to alleviate anxiety and pain during cannulation procedures. Patients wear VR headsets, immersing them in a therapeutic 3D environment designed to enhance comfort and overall experience during the procedure. This innovative, first-of-its-kind approach has the potential to transform the experience for patients, aligning with Dubai Health’s objective to elevate the standard of care and its vision to advance health for humanity.

In addition, Dubai Health’s Innovation and Digital Health team is also conducting a validation study on wearable ambulatory blood pressure monitoring technology using a smartwatch. The study evaluates the accuracy and effectiveness of this technology in delivering continuous blood pressure measurements, presenting a more convenient alternative to traditional methods. These initiatives underscore Dubai Health's ongoing efforts to incorporate advanced technology into healthcare to improve patient outcomes and streamline healthcare delivery.

Another project on display is the Ambient Clinical Documentation Solution, a tool designed to enhance clinical documentation efficiency by leveraging Generative AI. This solution enables clinicians to verbally document patient encounters, significantly reducing the time required for documentation. This allows clinicians to spend more time and provide better experience to our patients. The voice notes are processed by an AI-driven system that generates specialty-specific clinical notes, which clinicians then review and sign.

Atif Al Braiki, Chief Digital and AI Officer at Dubai Health,  commented, “Our participation in GITEX 2024 underscores our commitment to leveraging cutting-edge technology to transform healthcare delivery. By integrating AI and other advanced technologies in our day-to-day care, we are proud to be showcasing how we are constantly adapting to enhance patient outcomes, streamline operations, and set new standards in healthcare innovation. In line with our commitment to healthcare excellence, integrating these technologies will help us to realize our vision of advancing health for humanity.”

Dubai Health’s presence at GITEX 2024, being held at the Dubai World Centre, is a testament to its dedication to remaining at the forefront of the technological healthcare revolution, harnessing innovations to put the patient first.

Building on Dubai Health's vision to advance health for humanity, The Royal Marsden NHS Foundation Trust has been selected to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai's first integrated, comprehensive cancer hospital.

The partnership marks a significant step forward in enhancing the standard of cancer treatment in Dubai, where specialized and compassionate care will be accessible in one place.

As one of the world's leading hospitals dedicated to cancer diagnosis, treatment, research, and education, The Royal Marsden will work with Dubai Health to establish a model of excellence in comprehensive cancer care at HBRCH. Their renowned expertise will be leveraged across several key areas, including developing specialist, evidence-based models of care, early diagnosis, and treatment pathways that guide patients through every step of their journey.

The HBRCH program of care will span from early detection to treatment, recovery, and post-treatment support. A key focus of this partnership will be building a world-class, specialized team of cancer care professionals. This will involve creating a robust workforce plan, developing advanced training programmers, and fostering a culture of continuous learning. Additionally, the partnership will seek to establish a cancer research program, fostering a culture of discovering transformative advancements in cancer care.

Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, said, “We are honored to join forces with The Royal Marsden, a global leader in cancer research and treatment. Their renowned expertise and approach to care perfectly complement the care, learning, discovery, and giving missions of our integrated academic health system. Through this partnership, we are honoring the collective generosity of our esteemed donors whose unwavering support to Al Jalila Foundation is fulfilling our vision for the Hamdan Bin Rashid Cancer Hospital to become a beacon of hope for patients and families facing a cancer diagnosis. It propels us closer to achieving the Dubai Social Agenda 33 goal of delivering a world-class healthcare system of the highest efficiency and quality."

Dame Cally Palmer, Chief Executive, The Royal Marsden, said: “I am delighted that The Royal Marsden has been chosen to work in partnership with Dubai Health to advance the clinical development of the Hamdan Bin Rashid Cancer Hospital. This is an excellent opportunity for international collaboration, and to adapt the best practices in state-of-the-art healthcare provision and establish the structure upon which this advanced, innovative and future-looking hospital can be based.”

“At The Royal Marsden our integrated NHS and Private Care model, underpinned by a research and academic infrastructure, delivers outstanding personalized care for our patients. Through a staged program of work, The Royal Marsden and Dubai Health aim to establish a long-term strategic partnership that will not only develop a new hospital but support specialized cancer care across the wider healthcare system in Dubai,” she added.

Set to open in 2026, the HBRCH will offer a groundbreaking model of care under Dubai Health. As part of Dubai’s first integrated academic health system, the comprehensive cancer hospital will create multidisciplinary teams to spearhead a transformative shift in care delivery. Research and clinical trials will be at the heart of the hospital, fostering a culture of discovery and accelerating progress in cancer care. With 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus, the hospital is positioned to become a beacon of hope for cancer patients in the UAE and the region.

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the learning and discovery missions of Dubai Health, has signed a Memorandum of Understanding (MoU) with the American Dental Association Forsyth Institute (AFI), a top-tier, United States-based research institute focused on exploring the connections between oral health and overall well-being. The strategic partnership aims to advance oral health and related technology development in Dubai by fostering research and learning opportunities for students and faculty at MBRU’s Hamdan Bin Mohammed College of Dental Medicine (HBMCDM), aligning with Dubai Health’s evidence-based approach to advancing patient care.  The agreement was part of a broader visit by MBRU’s HBMCDM delegation to the United States, during which they engaged with leading academic institutions and explored avenues for international collaboration.

Through strategic partnership, Dubai Health and AFI will collaborate on joint research projects and student exchange programs to address oral health issues, ultimately improving dental care outcomes. The collaboration will also facilitate the organization of joint symposia, conferences, and workshops to foster knowledge exchange among oral health professionals. This partnership aligns with the mission of Dubai Health’s integrated academic health system, where learning and discovery inform evidence-based solutions that enhance patient outcomes and experiences.

Commenting on the partnership, Professor Manal Al Halabi, Dean of HBMCDM at MBRU, said, “This collaboration with the ADA Forsyth Institute represents a significant step forward in our efforts to elevate oral health research and education at MBRU. The agreement creates valuable opportunities for collaboration and knowledge exchange, ultimately leading to better oral health care.”

“ADA Forsyth has created an ecosystem for oral health technology development,” said AFI’s Chief Executive Officer, Dr. Wenyuan Shi, “Through this partnership with MBRU, we can extend access to this ecosystem to Dubai Health and promote oral health innovation and research collaboration globally.”

In line with MBRU’s commitment to global collaboration, a delegation from the Hamdan Bin Mohammed College of Dental Medicine (HBMCDM) recently visited leading dental schools in Boston to strengthen international partnerships. Led by Professor Manal Al Halabi, the delegation engaged with renowned institutions, including Tufts University and Boston University’s Henry Goldman School of Dental Medicine. During the visit, they participated in the DENTECH ADA Forsyth meeting, where Professor Al Halabi contributed as a panelist in a discussion on Global Innovation and Investment. The team also attended the Tufts Annual Implantology Symposium, with Professor Al Halabi joining the Dean’s Round Table discussion alongside esteemed leaders from prominent global dental institutions. Additionally, the delegation met with Dubai Health scholars in Boston to support their academic and professional development.

The delegation also included Dr. Eman Alnuaimi, Assistant Dean for Student Happiness and Wellbeing; Professor Momen Atieh, Chair of Oral Diagnostics and Surgical Sciences; Dr. Mohamed Jamal, Program Director for Endodontics; and Dr. Anas AlSalami, Program Director for Pediatric Dentistry.

April 04, 2024, Dubai: Al Jalila Foundation, which leads the giving mission of Dubai Health, announced that Saeed Ahmed Lootah Charity Foundation has donated AED 15 million to support the development of the Hamdan Bin Rashid Cancer Hospital, Dubai's first integrated, comprehensive cancer hospital. This donation underscores Saeed Ahmed Lootah Charity Foundation's commitment to advancing sustainable charitable and humanitarian work and reinforcing Dubai's pioneering role in healthcare excellence.

Set to open in 2026, the hospital honors the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum, paying tribute to his lifetime of service to the nation and extraordinary global philanthropic activities that continue to touch the lives of many around the world. The hospital is being developed with the support of generous donations received from philanthropists, government and non-government organizations, UAE businesses and corporates.

Engineer Hussain Nasser Lootah, Member of the Board of Trustees of the Saeed Ahmed Lootah Charity Foundation, said: “Inspired by our visionary leadership, which has embedded philanthropy into its core humanitarian strategies, the Saeed Ahmed Lootah Charity Foundation, led by H.E. Lieutenant General Dhahi Khalfan Tamim, Chairman of the Board of Trustees, remains committed to social responsibility, education, and medical research support. We are pleased to contribute towards the Hamdan Bin Rashid Cancer Hospital, aligning our efforts with Al Jalila Foundation to ensure equitable and essential access to cancer care. This partnership reflects the core principles of our esteemed founder, Haj Saeed Ahmed Lootah, who championed education, healthcare, and scientific research. Our dedication extends beyond borders, encompassing local and global charitable and humanitarian endeavors."

Dr. Thani Al Mheriri, CEO of Education & Health at Saeed Ahmed Lootah Charity Foundation, said: “By joining hands, we aim to make a meaningful impact in the fight against cancer and advancing medical research. Our dedication to medical education and healthcare is deeply rooted in our legacy; Dubai Medical College for Girls, which was established forty years ago as the first institution for medical education for girls in the Gulf region, is now a prominent contributor to the healthcare landscape."

Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “Donor support is an integral part of our success in developing the Hamdan Bin Rashid Cancer Hospital. We are grateful to Saeed Ahmed Lootah Charity Foundation, which has committed to helping us support cancer patients and their families. The hospital will bring together cancer expertise and make an invaluable contribution to Dubai’s healthcare sector, putting patient care first.”

"Together, we are one step closer to establishing a center of excellence that will transform cancer care in the UAE." he added.

The 116-bed hospital will occupy 56,000 square meters. It will provide best-in-class outpatient, ambulatory and diagnostic services as well as inpatient and surgical services in a nurturing environment that features personalized patient care.

As part of Dubai Health, the first integrated academic health system in Dubai, the comprehensive cancer hospital will benefit from a multidisciplinary team, including specialized nursing, offering patients a full spectrum of care services in one location, from early diagnosis to treatment and supportive care. Aligning with Dubai Health’s Patient First promise, select treatments and services will be made available to patients in the comfort of their homes, ensuring an easy and accessible continuum of care.

For more information on Al Jalila Foundation and its programs, please visit:
https://www.aljalilafoundation.ae

Dubai Health, the first integrated academic health system in Dubai, has announced the opening of applications for its graduate training programs offered by the Graduate Medical Education (GME) at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU).

The GME at MBRU offers an extensive range of training opportunities, including two internship programs, 20 residencies, and 15 fellowships spanning medical, dental, and surgical specialties. These programs have earned accreditation from key regional accreditation bodies, including the Saudi Commission for Health Specialties, the UAE National Institute for Health Specialties, and the Arab Board of Health Specializations.

Professor Sulaiman Alemran, Dean of Graduate Medical Education, commented: “As Dubai’s first academic health system, through the integration of care, learning, discovery, and giving, we have a unique opportunity to create an engine for innovation, connected for the patient - delivered through a culture of collaboration. We believe that through instilling this transformative mindset and uniting as one, we can advance health to new heights of patient-centric excellence. Leveraging the integrated academic health system of Dubai Health, our trainees have the unique opportunity to directly engage with patients across 6 hospitals, 27 ambulatory health centers, and 20 medical fitness centers at with Dubai Health.”

Dr. Rasha Buhumaid, Vice Dean and Designated Institutional Official at Graduate Medical Education and Assistant Professor of Emergency Medicine at MBRU said, "We offer 250 seats annually for enrollment in our graduate medical education programs. Our programs are designed to equip emerging healthcare professionals with well-rounded skills, ensuring their preparedness for the dynamic professional landscape. Trainees will benefit from experienced and dedicated faculty and clinical educators and partake in innovative research within their specialized field of interest, contributing to advancing medical knowledge. This approach aims to guarantee the quality of healthcare provided by future healthcare professionals, fostering a commitment to excellence and quality in their practice."

Registration for Graduate Medical Education (GME) at MBRU is currently open, with a deadline of March 22nd for residency programs. For internship and fellowship programs, the registration period extends until April 22nd.

To learn more and submit an application, please visit: https://www.mbru.ac.ae/graduate-medical-education/

In line with the UAE National Sports Strategy 2031 ..Dubai Academic Health Corporation and Dubai Sports Council sign MoU to boost the sports sector's support for humanitarian and charitable causes

Al Jalila Foundation, a global healthcare philanthropic organization dedicated to transforming lives through medical innovation, has signed a Memorandum of Understanding (MoU) with the Dubai Sports Council (DSC) aimed at enhancing the contributions of the sports sector towards humanitarian programs and charitable initiatives.

The signing of the agreement aligns with the UAE National Sports Strategy 2031 which was recently launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to promote community well-being through sports. The Strategy seeks to foster a culture of physical activity, improve the capabilities of sports professionals, identify promising athletes in educational institutions, and modernize sports education methods and regulations.

During the ceremony, the ‘Champions of Hope’ tribute wall, dedicated to recognizing extraordinary sports personalities who have made significant contributions to Al Jalila Foundation, was inaugurated.

The inauguration of the tribute wall and the MoU signing ceremony was attended by His Excellency Saeed Hareb, Secretary General of DSC; Nasser Aman Al Rahma, Assistant Secretary General of DSC; Dr. Amer Sharif, Chief Executive Officer of Dubai Academic Health Corporation (DAHC); Dr. Amer Al Zarooni, Chief Executive Officer of Al Jalila Foundation, and representatives of DSC and DAHC.

Al Jalila Foundation has been officially designated as the charity partner of the Dubai Sports Council, marking a significant collaboration between the two entities. Together, they will embark on a series of initiatives aimed at promoting sports philanthropy and fostering a culture of sports, physical activity and inclusive participation across all segments of society.

Dr Amer Al Zarooni, CEO of the Al Jalila Foundation, said “Philanthropy possesses an extraordinary capacity to create lasting change. United by the common language of sport, the collaboration between Al Jalila Foundation and the DSC symbolizes DAHC’s unwavering dedication to elevate the overall health and well-being of people in the UAE.”

He added: “Sports provide an incredible platform to reach hundreds of thousands of individuals, promoting healthy lifestyles and generating funds for charitable endeavors. We take immense pride in the support we receive from numerous sporting legends, and it is truly inspiring to witness globally recognized athletes utilizing their influence to bring about positive change in people's lives. The Champions of Hope tribute wall will stand as a lasting testament to compassion, generosity and empowerment, leaving a legacy for future generations."

His Excellency Saeed Hareb, Secretary General of DSC, expressed his delight in signing the agreement with Al Jalila Foundation and conveyed his deep admiration for the remarkable societal and humanitarian accomplishments made thus far. “The role of sports has proven to be instrumental in supporting philanthropic initiatives and advancing medical research, ultimately making significant contributions to patient recovery. Sports stars play crucial roles, not only in terms of achieving outstanding results and bringing happiness to their fans, but also in actively supporting community, sports and humanitarian initiatives. Their involvement highlights the tireless efforts of national institutions, with Al Jalila Foundation being at the forefront, in making a positive impact on society.”

His Excellency added: “We have witnessed successful collaborations between DSC and Al Jalila Foundation in the past, always uniting our shared objectives of national sports, humanitarian endeavours and community service to benefit humanity.”

Champions of Hope Tribute Wall

Symbolic of the remarkable strength of community within the realm of sports, the Champions of Hope tribute wall serves as a showcase for sports memorabilia, including two Guinness World Records that were achieved through items sold at the Al Jalila Foundation charity auction in 2015. Notably, among these record-breaking items is a race helmet worn by HH Sheikh Mohammed bin Rashid Al Maktoum during his triumphant victory at the FEI World Endurance Championship in 2012, which fetched an astounding AED24 million. Additionally, the display features the exceptional AED2.4 million Al Yamamah saddle generously donated by His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, which he rode to victory at the 2014 Altech FEI World Equestrian Games held in Normandy, France.

Since its establishment, Al Jalila Foundation has been harnessing the power of sports to support its healthcare philanthropic programmes. Over the years, the Foundation has been part of iconic sporting events to help raise awareness around a number of causes. Through its engagement in these iconic sporting occasions, the Foundation has generated substantial funds to support its various programs including 7 Emirates Run, Beat Diabetes Walk, Pink is Punk.

Overall, Al Jalila Foundation has held a total of 300 sporting events and raised almost AED10 million. The latest partnership with DSC will further contribute to realizing the Foundation’s objective to transform lives through sports.

As the official Sports Ambassador for Al Jalila Foundation, the esteemed former Real Madrid footballer Michel Salgado has made significant contributions by donating his customized boots to the Foundation and fostering fruitful collaborations with renowned footballer and former Real Madrid goalkeeper, Iker Casillas, as well as esteemed corporate fundraising partners. In close partnership with Clarence Seedorf, a four-time UEFA Champions League winner, the Foundation strives to amplify awareness regarding the importance of cultivating a healthy lifestyle, especially among the younger generation.

Notably, MMA coach Javier Mendez, alongside an impressive line-up of top-tier fighters including the current UFC Lightweight Champion Islam Makhachev, UAE Warriors fighter Emirati Hadi Al Husseini, and the UAE's pioneering Emirati female boxer Fahima Falaknaz, have generously contributed signed items and are actively engaged in multiple initiatives in collaboration with the Foundation.

Dubai Academic Health Corporation’s vision is to advance health for humanity through the integration of care, learning, discovery and giving. Al Jalila Foundation advances DAHC’s giving mission to impact lives and shape the future of health through philanthropy.

For more information about Al Jalila Foundation please visit: www.aljalilafoundation.ae

His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and Chairman of The Executive Council of Dubai attended a ceremony unveiling the design of the Hamdan Bin Rashid Cancer Hospital, part of Dubai Health. Set to be Dubai's first integrated, comprehensive cancer hospital, the event also announced the hospital's groundbreaking model of care.

Marking a significant step in terms of providing advanced and accessible cancer care, Dubai Health announced that the Hamdan Bin Rashid Cancer Hospital is to open in 2026. The hospital honors the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum, paying tribute to his lifetime of service to the nation and extraordinary global philanthropic activities that continue to touch the lives of many around the world.

The ceremony was held at the site allocated for the hospital in the presence of His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors; His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors; and Sheikh Rashid bin Hamdan bin Rashid Al Maktoum, President of the Hamdan bin Rashid Al Maktoum Establishment for Medical and Educational Sciences.

His Excellency Awadh Seghayer Al Ketbi, Director General of Dubai Health Authority (DHA); Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, and His Excellency Dr. Amer Ahmad Sharif, CEO of Dubai Health also attended the ceremony among other officials and donors.

The Hamdan Bin Rashid Cancer Hospital is being developed with the aid of generous donations received through Al Jalila Foundation, which leads Dubai Health's giving mission. The collective contributions of individuals and organizations will support the establishment of the 56,000²m hospital.

Reflection of Dubai Social Agenda 33
HH Sheikh Hamdan said, "The Hamdan Bin Rashid Cancer Hospital honors the humanitarian legacy of the late Sheikh Hamdan bin Rashid Al Maktoum. This new addition to the health system in Dubai will play a crucial role in achieving the Dubai Social Agenda 33 goal to deliver the most efficient world-class healthcare system of the highest quality."
HH Sheikh Hamdan thanked all donors who had contributed to the hospital project, highlighting their support as invaluable contributions to building the future of Dubai and its healthcare sector.

Beacon of hope
HH Sheikh Ahmed said, "The Hamdan Bin Rashid Cancer Hospital is a fitting tribute to the late Sheikh Hamdan Bin Rashid Al Maktoum, resonating with his belief that helping others was not just a duty but a blessing. The Hamdan Bin Rashid Cancer Hospital will stand as a beacon of hope, a hub of innovation, and a promise to provide excellent care to our patients in Dubai and beyond. With some of the world's leading experts, cutting-edge technology, and a compassionate approach, we will create an environment that fosters healing and resilience in the region."

HH Sheikh Mansour said, "The Hamdan Bin Rashid Cancer Hospital will break new ground in elevating cancer care standards, reaffirming Dubai Health's commitment to advancing health for humanity. Together, we will honor the legacy of the late Sheikh Hamdan Bin Rashid Al Maktoum and realize Dubai's ambition to be a global leader in healthcare innovation, ensuring access to world-class medical services for all."

The hospital, located in the Al Jaddaf area, is envisaged to host 50 clinics, 30 clinical research areas, 60 infusion rooms, 10 urgent care rooms, 5 radiotherapy rooms, and 116 inpatient beds. Enhancing the healing environment for patients and their families will be 19 gardens distributed across the hospital campus. Stantec, a global leader in sustainable design and engineering, has been appointed as the architect for the project.

As part of Dubai Health, the first integrated academic health system in Dubai, the comprehensive cancer hospital will benefit from a multidisciplinary team, including specialized nursing, offering patients a full spectrum of care services in one location, from early diagnosis to treatment and supportive care. Aligning with Dubai Health's 'Patient First' promise, select treatments and services will be made available to patients in the comfort of their homes, ensuring an easy and accessible continuum of care.  

HE Dr. Raja Easa Al Gurg said, "We extend our deepest gratitude to all our generous donors for upholding the spirit of giving, echoing the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum. The hospital is a collective endeavor, a testament to our shared humanity, uniting us against a global challenge."

New model of care
The hospital will spearhead a transformative shift in care delivery, moving from a traditional inpatient model to an ambulatory model of care. This shift includes integrating primary care with diagnosis and treatment to offer detection and intervention at earlier stages of the patient's journey.

Research and clinical trials will be at the heart of the hospital's array of services, fostering opportunities for discovering the best patient outcomes through personalized, patient-centric, evidence-based care.

In line with the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, for the future of the emirate’s healthcare sector, His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and Chairman of The Executive Council of Dubai, approved the new brand identity for ‘Dubai Health’, the emirate’s first integrated academic health system that seeks to enhance the quality of patient care in the city.

The new identity encapsulates essential pillars that underscore collaborative teamwork, aiming to consolidate Dubai's leadership in advancing healthcare excellence across the domains of health, education and research.

HH Sheikh Hamdan bin Mohammed directed the transformation of Dubai into a leading global model for advancing human health by providing highly efficient medical services and adhering to the best international practices in healthcare. He also underscored the significance of enhancing the academic aspect of the healthcare system to achieve the desired outcomes for the sector in the next phase.

The unveiling of the new brand identity for 'Dubai Health' took place at a press conference held at the Dubai Press Club. The event was attended by Dr. Amer Sharif, CEO of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), along with several healthcare providers in the emirate.

Dubai Health – Brand Identity

The ‘Dubai Health’ brand identity finds its inspiration in the attributes of care, learning and discovery, rooted in a strong tradition of giving as depicted in the brand’s logo. Symbolised by three arches anchored by a foundation, the logo’s central arch serves as a representation of care, expressed through compassionate guardianship and nurturing of boundless potential. The secondary arches represent learning and discovery, while the solid base of the logo stands for giving.

Through the integration of these four missions, Dubai aligns with leading academic health systems worldwide, enhancing patient outcomes and fostering accessibility and sustainability within its healthcare sector.

His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, said: “The new brand identity builds on Dubai’s robust healthcare system and is a significant step towards shaping a new paradigm of excellence for the sector. The healthcare sector is the cornerstone of the wellbeing of our communities and pivotal to realising our vision of a world-class healthcare system. We are dedicated to continually enhancing Dubai's health system and helping it evolve with a transformative care model poised to tangibly enhance community health and shape the future of healthcare in Dubai and beyond. Strengthening the sustainability and resilience of our health sector is integral to achieving the objectives outlined in the Dubai Economic Agenda, D33.”

 Dubai Health – Dubai’s integrated academic health system

As the first academic health system in the city, ‘Dubai Health’ is strongly committed to providing the best outcomes for patients through evidence-based care. ‘Dubai Health’ oversees six hospitals, 26 ambulatory health centres and 20 medical fitness centres. The Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and Al Jalila Foundation also operate under the umbrella of ‘Dubai Health’.

His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors, said: “‘Dubai Health’ underscores our commitment to enhancing the health and well-being of the community in Dubai. Academic health systems worldwide have consistently demonstrated an elevated standard of patient care by seamlessly integrating knowledge, people and capabilities. The world's top 10 ranked hospitals are affiliated with renowned medical schools and universities within academic health systems. Through the integration of care, learning, discovery and giving, 'Dubai Health' aligns with global best practices, harnessing the transformative power of an integrated academic health system for the emirate.”

Dubai Health – Patient First Promise

‘Dubai Health’s’ primary value is ‘Patient First’, which encompasses a dedication to delivering high-quality care, ensuring patient safety and promoting a positive patient experience.

Dr. Amer Sharif said: “We are dedicated to achieving integration of the health system through the new corporate identity, encompassing care, learning, discovery and giving, with the aim of positioning ‘Dubai Health’ as a global benchmark in patient care and health outcomes. This marks a new phase in realising the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum to consolidate Dubai’s position as a leading global healthcare destination.

“Our mission of integration serves as an engine for innovation, dedicated to the patient. We believe that through instilling this transformative mindset and uniting as one system we can advance health to new heights of patient-centric excellence. The new corporate identity reflects our vision to contribute to Dubai's pursuit of a sustainable, knowledge-based economy, supporting the growth and performance of the health sector,” Dr. Sharif said.

Dr. Sharif added: “In the ever-progressing field of medicine and health sciences, continuous learning is pivotal. At the heart of our academic health system is a commitment to ensure that we are well-versed in the latest medical discoveries, technological breakthroughs and progressive best practices. This scholarly-driven ethos not only advances the healthcare field but also enhances the care received by our patients.”

Unified Vision

During the press conference, Dr. Sharif explained that the Dubai Health Authority (DHA) is responsible for ensuring a high-quality healthcare system in the emirate. This is achieved by organising and developing necessary policies and legislation to safeguard public health, enhance the standard of living, and introduce a health strategy geared towards enabling Dubai to meet its future needs.

On the other hand, ‘Dubai Health’, with its primary commitment to enhancing human health and a dedicated focus on improving the patient experience within the healthcare sector, assumes the responsibilities of establishing global standards grounded in scientific evidence for patient care. It aims to enhance health outcomes through rigorous scientific research and bring about a transformative shift in education by refining the patient journey and preparing qualified professionals to meet future requirements. Additionally, it emphasises the significance of health endowment due to its impact on supporting health and preserving individual lives.

Dr. Sharif noted that the new brand identity of ‘Dubai Health’, along with its future vision, aligns with and complements the Dubai Health Authority's efforts to strengthen Dubai's standing as a global exemplar in delivering the best healthcare and treatment to patients.

‘Dubai Health’ provides a spectrum of benefits designed to attract strategic investments in health sciences, foster governance development, enhance operational efficiency, improve healthcare outcomes, build local health capabilities, attract and retain distinguished talent and promote research and innovation.

Milestones

‘Dubai Health’s’ team of over 11,000 professionals collaborate across multidisciplinary teams to provide compassionate, evidence-based care centred on the patient and their families. ‘Dubai Health’ has attained several milestones, with its hospitals recording over 4.7 million outpatient visits, nearly 350,000 emergency department visits and over 60,000 patient admissions in 2022. Notably, it has drawn in over 1,000 learners from various disciplines worldwide, provided 60 scholarships and 100 research grants and offered a total of 8,686 patients in need medical support.

Since 2016, ‘Dubai Health’ has also contributed significantly to studies and research, issuing more than 1,114 scientific and clinical research papers. The importance of this research lies in recognising that individual well-being is a pivotal factor in prosperity and psychological comfort, subsequently impacting productivity and national development. The advancement of the academic healthcare sector stands as a key indicator of a country's progress and the well-being of its citizens.

Dubai Academic Health Corporation was established as per Law No. (13) of 2021, issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai. Effective 11 November 2023, Dubai Academic Health Corporation will operate under the new brand name 'Dubai Health'.

The International Hospital Federation (IHF), a global organisation dedicated to advancing and promoting excellence in healthcare delivery and management worldwide, announced that it has elected Emirati Dr. Muna Tahlak, Chief Medical Officer of Dubai Academic Health Corporation (DAHC), Vice Provost Clinical Practice of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and CEO of Latifa Hospital for Women and Children, as President of the Federation during the World Hospital Congress in Lisbon.

Dr. Tahlak's election as President of IHF is a major milestone for the UAE on the global healthcare front. As the first Arab woman and Emirati to hold this esteemed position, it underscores the UAE's commitment to both advancing the role of women across diverse fields and promoting excellence in the healthcare sector. This achievement also marks a remarkable moment in the history of the IHF, with Dr. Tahlak assuming the highest international position ever held within the organisation.

The IHF Governing Council voted to elect Dr. Tahlak as the new IHF President. In doing so, Dr. Tahlak ends her term as President Designate and now begins her two-year term as President of the IHF, succeeding Deborah J. Bowen, FACHE, CAE, President, and Chief Executive Officer of the American College of Healthcare Executives.

Dr. Tahlak expressed her gratitude and honour on being appointed, stating: “I extend my heartfelt appreciation to our visionary leadership for their unwavering commitment to empowering women. Emirati women have consistently excelled in diverse high-ranking roles across various domains. Our nation has also consistently offered abundant opportunities to foster the progress and specialisation of Emirati women, particularly within the medical field.

“This victory highlights not only the progress that Emirati women have made but also reflects the leading position of UAE’s health sector. I am honoured to represent the UAE and fellow Emirati women on such an important global platform,” she added.

Dr. Tahlak also noted that her work with the IHF over the past seven years has provided her with a platform to showcase the exemplary work of hospitals in the UAE and the invaluable contributions of Emirati women on a global scale.

Dr. Amer Sharif, CEO of Dubai Academic Health Corporation, congratulated Dr. Tahlak on her well-deserved appointment as the President of the International Hospital Federation, emphasising her exceptional leadership, expertise, and remarkable contributions to the healthcare system in Dubai and beyond. He also expressed his pride in Dr. Tahlak’s accomplishments and the recognition she brings to the exceptional talent of Emirati women on the global stage.

“This is an incredibly proud moment for the entire healthcare sector in the UAE. Emirati women have consistently excelled across various domains, particularly in the medical field, making substantial contributions to the nation's growth and development. Dr. Tahlak's leadership and dedication play a crucial role in fulfilling DAHC's mission to impact lives and shape the future of health through the integration of care, learning, discovery, and giving,” he said.

Dubai Academic Health Corporation (DAHC), Dubai’s first integrated academic health system, announced that it has earned the prestigious Gold Seal of Approval® by the Joint Commission International (JCI) across all its hospitals and primary care centers.

By maintaining its international accreditation, DAHC demonstrates a steadfast dedication to upholding healthcare excellence for patients and their families. The accreditation also reflects its commitment to becoming a global leader in providing exceptional patient care by maintaining the highest quality and safety standards.

The Joint Commission International, a leading accreditation body for hospitals and healthcare organizations worldwide, conducted a thorough evaluation process to award DAHC hospitals with the Gold Seal of Approval®. This evaluation concentrated on critical operational systems related to safety and encompassed various facets of patient care. JCI's comprehensive assessment examined the hospitals' adherence to rigorous global standards, with a particular emphasis on patient safety, clinical quality, and risk management protocols.

Dr. Muna Tahlak, Chief Medical Officer of DAHC and CEO of Latifa Hospital, said: “Receiving JCI accreditation across Dubai Academic Health Corporation hospitals and healthcare facilities is a tremendous accomplishment that speaks volumes about our unwavering commitment to delivering exceptional patient care. This recognition validates the hard work and dedication of our teams and demonstrates our ongoing pursuit of excellence in healthcare in line with our ‘Patient First’ promise.”

Joel Roos, Vice President, International Accreditation, Quality Improvement and Safety, Joint Commission International, said: “The accreditation offered by JCI equips hospitals with processes that foster improvements across multiple areas, such as staff education advancements and the implementation of leading practices within the hospital environment. We commend Dubai Academic Health Corporation for its dedication to becoming a quality improvement organization and reaching this prestigious milestone, which showcases a strong commitment to patient safety and quality.

By successfully securing JCI's accreditation, patients and their families can have even greater confidence in the care they receive at DAHC hospitals, affirming the organization's pledge to place its patients first.

Dubai Health welcomed Professor Yasmine Belkaid, the winner of the Great Arab Minds 2024 in Medicine, to deliver a lecture and engaging discussion at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). Renowned for her groundbreaking research in immunology, Professor Belkaid shared transformative insights with a diverse audience of healthcare professionals and students.

During her lecture, ‘Microbiota Control of Immunity,’ Professor Belkaid shared her groundbreaking research on how the immune system differentiates between beneficial and harmful microbes. She also shared insights from her scientific journey, offering students valuable perspectives on tackling immune and infectious diseases through innovative approaches. With over 220 published studies in infection and immunity, Professor Belkaid has made significant contributions to sustainable solutions in healthcare and nutrition. The session generated enthusiasm among students and healthcare professionals, offering a valuable opportunity to learn from one of the world’s leading immunologists.

The session was attended by Dr. Amer Sharif, CEO of Dubai Health and President of MBRU; Professor Alawi Alsheikh-Ali, Chief Academic Officer at Dubai Health and Provost of MBRU, alongside students and healthcare professionals.

Professor Belkaid also toured research facilities at MBRU, including the Biomedical Research Center, the Center for Applied and Translational Genomics (CATG), and the Biobank, where she expressed appreciation for the university's infrastructure and academic programs. She also met with MBRU students from various disciplines to discuss recent advancements in immunology and health sciences.

H.E. Dr. Raja Easa Al Gurg, Chairperson of MBRU’s Board of Trustees and Dubai Health Board Member, said: “Professor Yasmine Belkaid exemplifies the extraordinary potential of Arab women to drive transformative advancements in science and healthcare. Her achievements inspire future generations, demonstrating the Arab world’s ability to lead meaningful innovations for the benefit of humanity. MBRU is proud to be a platform for knowledge exchange and collaboration with scientific talents, furthering our mission of fostering continuous learning and discovery within our integrated academic health system.”

Her Excellency added: “We were honored to host Professor Yasmine Belkaid, and I extend my congratulations on her well-deserved recognition. I also thank her for sharing her invaluable insights with our community.”

Dr. Amer Sharif, CEO of Dubai Health and President of MBRU, said: “We were privileged to welcome Professor Yasmine Belkaid, an inspiring example of Arab scientific excellence whose work has greatly benefited humanity. This visit reflects our commitment to fostering a learning environment that nurtures the next generation of healthcare professionals and serves as a role model for aspiring researchers throughout the Arab world.”

He added, “We are deeply grateful for her visit and impactful lecture, which enriched the knowledge of our students and academic community. I also want to thank the organizers of the Great Arab Minds Award for highlighting such exceptional talents.”

Professor Alawi Alsheikh-Ali, Chief Academic Officer at Dubai Health and Provost of MBRU, stated: “Hosting Professor Yasmine Belkaid provided an exceptional opportunity for our students and medical community to deepen their understanding of immunology and its role in combating immune and infectious diseases. Her visit underscores our commitment to advancing science and learning by preparing the next generation of specialized scientists and researchers.”

He added: “We are grateful to Professor Belkaid for sharing her invaluable insights and engaging with our academic community. Her contributions not only inspire our students and professionals but also elevate the pursuit of excellence in research and discovery.”

As the first Arab woman to lead the Institute Pasteur in France, Professor Belkaid’s research has transformed our understanding of the immune system, paving the way for breakthroughs in treating immune-related conditions. Her achievements reflect her dedication to advancing science and humanity, aligning seamlessly with MBRU’s vision of integrated learning, discovery, and innovation.

Let’s get moving together for a healthier team. We encourage everyone to participate in the various activities taking place across the city of Dubai.

Dubai Health is all set to participate in Dubai Run, and contribute to turning Dubai into the world's most active city. 

Dubai Health has announced that eight Emirati scholars have secured residency training positions in Canada. This achievement was facilitated through Dubai Health’s Academic Mentorship Program at Mohammed Bin Rashid University of Medicine and Health Sciences’ Deanship of Graduate Medical Education, which aims to cultivate the next generation of highly skilled healthcare professionals equipped to address the evolving demands of patient care.

This latest cohort brings the total number of Emirati scholars pursuing residency programs in North America through Dubai Health’s program to 38. The current group of scholars will specialize in General Surgery, Internal Medicine, Emergency Medicine, Orthopedic Surgery, and Diagnostic Radiology. Residency programs will range from three to five years, depending on the chosen speciality.

Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, stated: “This achievement exemplifies the strength of our learning mission, one of the four core missions of Dubai Health. It reflects the high standard of medical education, mentorship, and clinical training that MBRU provides as part of Dubai’s integrated academic health system. The success of these scholars in securing residency positions abroad reinforces our commitment to preparing medical professionals who can thrive in a global healthcare landscape. I am proud of their dedication and equally proud of the graduate medical education team that has guided and supported them.”

Professor Suleiman Al Emran, Dean of Graduate Medical Education at MBRU, confirmed that the doctors will leave for Canada in the second quarter of 2025. He highlighted that these training programs will significantly refine the doctors' skills and capabilities, ultimately enhancing and fulfilling Dubai Health’s ‘Patient First’ promise.

Dr. Rasha Buhumaid, Vice Dean of Graduate Medical Education at MBRU, said: "These residency training placements reflect our commitment to providing our learners with unparalleled opportunities for professional growth. By enabling them to gain international clinical experience, we are fostering a generation of medical professionals who will advance healthcare excellence in the UAE. This achievement reflects the dedication of our scholars and the strength of our academic mentorship programs.”

The doctors selected for this opportunity include Dr. Hend Al-Awadhi, Dr. Fatima Abdulaziz Al-Baftah, and Dr. Ahmed Sahib Al-Habshi, specializing in General Surgery; Dr. Mizna Ali Hussein, and Dr. Salma bin Hindi, specializing in Internal Medicine; Dr. Hind Sameh Al-Halyan, specializing in Orthopedic Trauma Surgery; and Dr. Mohammed Al Banna, specializing in Emergency Medicine; and Dr. Ahmed Saleh Al Haj, specializing in Diagnostic Radiology.

Dr. Hend Al-Awadhi, one of the doctors selected for training at McMaster University in General Surgery, said: “I am honored to receive this incredible training opportunity from MBRU and Dubai Health. It marks a turning point in my academic and professional journey that will enable me to give back to my country and aid the progression of our healthcare sector.”

These residency training opportunities, facilitated by Dubai Health's Academic Mentorship Program for Physicians, underscore the organization’s commitment to cultivating local talent and enhancing healthcare excellence. Dubai Health aims to expand the training opportunities in North America in the coming years, ensuring a robust and future-ready healthcare workforce.